CSIMarket



Kymera Therapeutics Inc.  (KYMR)
Other Ticker:  
 

Cumulative Kymera Therapeutics's Leverage Ratio for Trailing Twelve Months Period

KYMR's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

KYMR Leverage Ratio for Trailing Twelve Months Period

(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
Y / Y Equity Growth 44.58 % 51.02 % 63.95 % - -
Y / Y Total Liabilities Growth 27.92 % 62.33 % -78.93 % - -
Leverage Ratio for Trailing Twelve Months Period 0.06 0.06 0.06 0.16 0.18
Total Ranking # 927 # 1101 # # 1109 # 1315
Seq. Equity Growth -7.18 % -11.26 % 87.19 % -6.23 % -3.04 %
Seq. Total Liabilities Growth 1.88 % -2.06 % 7.2 % 19.59 % 29.29 %


Leverage Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Despite net new borrowings of 1.88% Kymera Therapeutics managed to unchange Leverage Ratio for Trailing Twelve Months Period in II. Quarter to 0.06, below Kymera Therapeutics's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Pharmaceuticals industry 111 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Kymera Therapeutics. While Leverage Ratio for Trailing Twelve Months Period total ranking has improved so far to 927, from total ranking in previous quarter at 1101.

What is Leverage Ratio?
Who are KYMR's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 112
Sector # 433
S&P 500 # 926


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.71 0.56 0.38
(Mar 31 2021)   (Jun 30 2022)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2022, within Biotechnology & Pharmaceuticals Industry Leverage Ratio for Trailing Twelve Months Period
Acasti Pharma Inc.  0.17 
Talis Biomedical Corporation  0.16 
Syndax Pharmaceuticals Inc.  0.16 
Compass Therapeutics Inc.  0.15 
Bioatla Inc.  0.15 
Sanara Medtech Inc.  0.15 
Protagonist Therapeutics inc.  0.15 
Neoleukin Therapeutics Inc.  0.15 
Homology Medicines Inc  0.14 
Zai Lab Limited  0.14 
Vor Biopharma Inc.  0.14 
Crispr Therapeutics Ag  0.14 
Dyadic International Inc  0.13 
Quanterix Corp  0.13 
Allovir Inc.  0.13 
Shattuck Labs Inc.  0.13 
Catalyst Biosciences Inc.  0.13 
Microbot Medical Inc  0.12 
Solid Biosciences Inc.  0.12 
Jounce Therapeutics inc.  0.12 
Passage Bio inc.  0.12 
Tarsus Pharmaceuticals Inc.  0.11 
Relay Therapeutics Inc.  0.11 
Inhibikase Therapeutics Inc.  0.11 
Assembly Biosciences inc.  0.11 
Mymd Pharmaceuticals Inc.  0.11 
Atyr Pharma Inc.  0.11 
Replimune Group Inc.  0.10 
Quince Therapeutics Inc.  0.10 
Relmada Therapeutics Inc.  0.10 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LMFA's Profile

Stock Price

LMFA's Financials

Business Description

Fundamentals

Charts & Quotes

LMFA's News

Suppliers

LMFA's Competitors

Customers & Markets

Economic Indicators

LMFA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071